Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo

Ulinastatin, a urinary trypsin inhibitor (UTI), is widely used to clinically treat lipopolysaccharide (LPS)-related inflammatory disorders recently. Adherent pathogen-associated molecular patterns (PAMPs), of which LPS is the best-studied and classical endotoxin produced by Gram-negative bacteria, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ru, Jiang-Ying, Xu, Hai-Dong, Shi, Dai, Pan, Jun-Bo, Pan, Xiao-Jin, Wang, Yan-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2016
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091469/
https://www.ncbi.nlm.nih.gov/pubmed/27638499
http://dx.doi.org/10.1042/BSR20160234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091469/
https://www.ncbi.nlm.nih.gov/pubmed/27638499
http://dx.doi.org/10.1042/BSR20160234

Ejemplares similares